Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Classificação em ações
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Preço da ação
$20.91
Valor de mercado
$7.57B
Variação (1 dia)
-8.26%
Variação (1 ano)
41.25%
País
CN
Negociar Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Categoria
Healthcare
Receita da Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Receita em Jun 2026 TTM: $1.06B
De acordo com os últimos relatórios financeiros da Asymchem Laboratories (Tianjin) Co., Ltd., a receita atual da empresa (TTM) é $1.06B. Em 2024, a empresa obteve uma receita de $795.26M uma diminuição em relação a a receita do ano 2023, que foi de $1.11B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Asymchem Laboratories (Tianjin) Co., Ltd. de 2011 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $1.06B | 11.34% |
| 2025 | $953.37M | 19.88% |
| 2024 | $795.26M | -28.06% |
| 2023 | $1.11B | -25.46% |
| 2022 | $1.48B | 103.50% |
| 2021 | $728.79M | 51.78% |
| 2020 | $480.16M | 35.91% |
| 2019 | $353.28M | 32.44% |
| 2018 | $266.75M | 21.96% |
| 2017 | $218.72M | 37.65% |
| 2016 | $158.90M | 24.23% |
| 2015 | $127.91M | 10.62% |
| 2014 | $115.63M | 29.23% |
| 2013 | $89.48M | 31.47% |
| 2012 | $68.06M | 5.76% |
| 2011 | $64.35M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $12.62B | 1,089.29% |
US
|
|
| $2.23B | 109.89% |
US
|
|
| $15.74B | 1,383.22% |
AU
|
|
| $9.57B | 801.80% |
BE
|
|
| $6.02B | 467.25% |
NL
|
